Business Context and Reporting Period
This Form 8-K Current Report was filed by nLIGHT, Inc. on March 4, 2021, reporting events occurring on March 3, 2021. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "LASR".
Key Financial Metrics and Transaction Details
The filing details an underwritten public offering of common stock rather than periodic financial performance metrics. Key transaction figures include:
- Shares Offered: 2,205,883 shares of common stock.
- Public Offering Price: $34.00 per share.
- Price to Company: $32.64 per share.
- Expected Net Proceeds: Approximately $71.6 million.
- Over-Allotment Option: Underwriters have a 30-day option to purchase up to 330,882 additional shares, which would increase total net proceeds to approximately $82.4 million.
- Use of Proceeds: Working capital, capital expenditures, and general corporate purposes.
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes
The primary material change is the execution of an underwriting agreement with Stifel, Nicolaus & Company, Incorporated and Raymond James & Associates, Inc. as representatives. This transaction represents a significant capital raise event. Additionally, certain officers and directors have entered into 60-day "lock-up" arrangements prohibiting the sale of Company securities.
Guidance, Outlook, and Risks
Outlook: The closing of the offering is expected to occur on or about March 8, 2021, subject to customary closing conditions.
Risks and Contingencies: The Underwriting Agreement contains customary representations, warranties, indemnification obligations, and termination provisions. The success of the offering is contingent upon the satisfaction of closing conditions. The filing notes that representations were made solely for the benefit of the parties to the agreement and may be subject to limitations.
Investor Verification Checklist
- Verify the final closing date of the offering (expected March 8, 2021).
- Confirm whether the underwriters exercise the option to purchase the additional 330,882 shares.
- Review the final prospectus supplement for any changes to the use of proceeds or offering terms.
- Monitor the impact of the 60-day lock-up period on secondary market liquidity.
- Check subsequent filings for the actual net proceeds received after deducting all offering expenses.